Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma
Status:
Recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
Radiotherapy (RT) is an important option for patients with limited stage FL. The recommended
approach for patients with limited stage FL by The National Comprehensive Cancer Network
(NCCN) is 24Gy~30Gy consolidation RT following effective systemic therapy. There is no
universal consensus for a ''standard'' RT field size in the treatment of limited stage FL.
The involved-site radiotherapy (ISRT) has been treated effectively for these patients.
However, the certain target volumes of ISRT need to be defined for patients with limited
stage FL after effective chemotherapy.